SPECIALTY CARE 
Nephrology Members
Michigan Collaborative for Type 2 Diabetes brings together primary care, endocrinology, and nephrology teams to engage in statement collaborative quality improvement. Currently, 14 nephrology practices participate in the collaborative.
The MCT2D Kidney Initiative seeks to engage and empower medical providers and patients across the state of Michigan to support the dissemination and implementation of evidence-based strategies that will prevent and slow the progression of kidney disease.]
Currently, 94 nephrologists in Michigan participate in MCT2D, representing 42% of nephrologists across the state. MCT2D has partnered with BCBSM to determine a model for attributing patients to nephrologists and over 8,000 patients represented in the MCT2D dashboards are currently attributed to one of our participating nephrologists.
MCT2D Nephrology Practices
Click on the icon in the top left corner of the map to open a directory list of our member endocrinology and nephrology practices. Clicking on an individual practice name will show you its address and the physicians who practice there.
MCT2D Nephrology Lead
Michael Heung, MD, is a nephrologist at the University of Michigan, where he serves as the Associate Chief of Nephrology and chairs the nephrology quality improvement committee.
Download Value-Based Reimbursement (VBR) requirements
Participating practices and POs can download a one-page guide to value-based reimbursement (VBR) for the 2024-2025 year.
VBR for continuing sites (PDF)
Nephrology Initiatives
Increasing Urine Microalbumin Testing
Elevated urine albumin is a well-established risk factor for adverse outcomes including kidney disease progression, yet is often not assessed. We work with partners to address potential barriers to testing.
Prescribing of GLP-1 Receptor Agonists & SGLT2 inhibitors
New classes of medications have been shown to improve glucose control, decrease mortality, slow chronic kidney disease progression and support weight loss.
Nephrology Related MCT2D Webinars
Specialty Practice Point-of-Care Tools
Subscribe to the MCT2D Newsletter
Once per month we deliver news, updates, events, and more directly to you!
ccteam@mct2d.org
Support for The Michigan Collaborative for Type 2 Diabetes (MCT2D) is provided by Blue Cross and Blue Shield of Michigan as part of the BCBSM Value Partnerships program.
Although Blue Cross Blue Shield of Michigan and MCT2D work collaboratively, the opinions, beliefs and viewpoints expressed by the author do not necessarily reflect the opinions, beliefs and viewpoints of BCBSM or any of its employees.